-65.7%
MRNA vs EQIX
+34.9%
-100.6%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | EQIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +4.6% |
| 7D | -1.1% | +0.2% | -1.3% | -1.2% |
| 30D | +126.1% | -2.5% | +128.6% | +128.6% |
| 3M | +190.0% | 0.0% | +190.1% | +186.9% |
| 6M | +157.2% | +7.6% | +149.6% | +143.6% |
| YTD | +388.2% | +37.5% | +350.7% | +295.9% |
| 1Y | +467.0% | +32.9% | +434.1% | +371.6% |
| 3Y | +36.1% | +42.8% | -6.7% | +4.7% |
| All | -65.7% | +34.9% | -100.6% | -71.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EQIX.
Daily Out/Under-Performance
Portfolio return minus EQIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded EQIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling